Functionalized layered double hydroxide nanoparticles as an intelligent nanoplatform for synergistic photothermal therapy and chemotherapy of tumors

Colloids Surf B Biointerfaces. 2022 Feb:210:112261. doi: 10.1016/j.colsurfb.2021.112261. Epub 2021 Dec 7.

Abstract

In this work, a novel layered double hydroxide (LDH)-based multifunctional nanoplatform was built for synergistic photothermal therapy (PTT)/chemotherapy. The platform was modified using the peptide B3int to target cancer cells with overexpression of integrin αvβ3. Indocyanine green (ICG) and doxorubicin (DOX) were loaded into the nanocarrier (LDH-PEG-B3int NPs) to form a system having a high drug loading (18.62%) and a remarkable photothermal conversion efficiency of 25.38%. It also showed pH-responsive and near-infrared (NIR)-triggered DOX release. In vitro and in vivo studies indicated that the anti-tumor activity of the combined delivery system was significantly higher than that of a single delivery system. This co-delivery nanosystem may be helpful for future application in the clinical treatment of cancer.

Keywords: B3int; Layered double hydroxide; Nano-drug delivery system; Stimulus-responsive drug release.

MeSH terms

  • Doxorubicin / pharmacology
  • Drug Delivery Systems
  • Drug Liberation
  • Hydroxides
  • Hyperthermia, Induced*
  • Nanoparticles*
  • Phototherapy
  • Photothermal Therapy

Substances

  • Hydroxides
  • Doxorubicin